Ironwood Pharma (NASDAQ: IRWD) reported Q3 EPS of $0.24, $0.13 better than the analyst estimate of $0.11. Revenue for the quarter came in at $122.06 million versus the consensus estimate of $72.9 million.

GUIDANCE:

Ironwood Pharma sees FY2025 revenue of $290-310 million, versus the consensus of $279.4 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.